Shares in Novo Nordisk rose on Monday, after it got U.S. approval for its weight-loss drug Wegovy to treat a serious liver ...

Novo Nordisk shares were climbing Monday after the Food and Drug Administration approved the popular weight-loss drug Wegovy ...

Novo Nordisk A/S shares advanced after the drugmaker’s blockbuster weight-loss drug Wegovy received US approval to treat a ...

Eli Lilly is a leader in the market for GLP-1 medicines. The company's Zepbound, indicated for weight loss, is racking up ...

Novo Nordisk (NYSE: NVO) first earned U.S. approval for its now-famous weight management medicine Wegovy in June 2021. That marked the beginning of a strong run for the company on the stock market.

FAT jab users are scrambling to buy Mounjaro before price hikes of more than 50 per cent. Pharmacies reported an influx of ...

A growing concern is shaking the medical world, reports of counterfeit Ozempic have surfaced, leading to alarming health ...

Some women are complaining of 'Ozempic vulva' and GLP-1 medications can causes changes to women's private parts.

Ozempic vulva' explained as several women have shared their experience of the rare side effect from using the semaglutide medication to aid weight-loss.